LeadIQ logo
Learn more at LeadIQ.com

Insights

Sustainable Diagnostics Amprion's focus on neurodegenerative disorder diagnostics aligns with the growing demand for sustainable healthcare solutions, presenting a sales opportunity in the environmentally conscious market segment.

Strategic Partnerships Partnerships with pharmaceutical companies for developing therapies opens avenues for collaboration and potential cross-selling opportunities for innovative diagnostic tools offered by Amprion.

Funding for Growth Recent financing rounds totaling $21.1 million provide Amprion with resources to expand its operations, indicating a potential increased demand for its products and services in the market.

Innovation in Diagnostics The launch of new diagnostic tools like SAAmplify and cerebrospinal fluid biomarker panels showcases Amprion's commitment to innovation, appealing to healthcare providers seeking advanced diagnostic solutions.

Collaborative Research Collaboration with organizations like the ALS Network and NIH researchers not only enhances Amprion's credibility but also presents sales opportunities through joint research projects and data exchange for mutual benefit.

Similar companies to Amprion

Amprion Tech Stack

Amprion uses 8 technology products and services including Microsoft Clarity, Font Awesome, jQuery Migrate, and more. Explore Amprion's tech stack below.

  • Microsoft Clarity
    Analytics
  • Font Awesome
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • RSS
    Miscellaneous
  • Priority Hints
    Performance
  • Cloudways
    Platform As A Service
  • WPForms
    Web Platform Extensions

Media & News

Amprion's Email Address Formats

Amprion uses at least 2 format(s):
Amprion Email FormatsExamplePercentage
First.Last@amprionme.comJohn.Doe@amprionme.com
38%
First@amprionme.comJohn@amprionme.com
34%
Last@amprionme.comDoe@amprionme.com
16%
First.Middle@amprionme.comJohn.Michael@amprionme.com
3%
First.Last@amprionme.comJohn.Doe@amprionme.com
3%
FLast@amprionme.comJDoe@amprionme.com
3%
First.Last@amprionme.comJohn.Doe@amprionme.com
3%
FLast@ampriondx.comJDoe@ampriondx.com
50%
First@ampriondx.comJohn@ampriondx.com
50%

Frequently Asked Questions

Where is Amprion's headquarters located?

Minus sign iconPlus sign icon
Amprion's main headquarters is located at 149 New Montgomery St 4fl San Francisco, California 94105 US. The company has employees across 2 continents, including North AmericaEurope.

What is Amprion's official website and social media links?

Minus sign iconPlus sign icon
Amprion's official website is ampriondx.com and has social profiles on LinkedIn.

How much revenue does Amprion generate?

Minus sign iconPlus sign icon
As of October 2024, Amprion's annual revenue reached $3.8M.

What is Amprion's SIC code NAICS code?

Minus sign iconPlus sign icon
Amprion's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Amprion have currently?

Minus sign iconPlus sign icon
As of October 2024, Amprion has approximately 29 employees across 2 continents, including North AmericaEurope. Key team members include Chief Operating Officer: B. V.Chief Commercial Officer: B. C.Chief Marketing Officer: C. H.. Explore Amprion's employee directory with LeadIQ.

What industry does Amprion belong to?

Minus sign iconPlus sign icon
Amprion operates in the Biotechnology Research industry.

What technology does Amprion use?

Minus sign iconPlus sign icon
Amprion's tech stack includes Microsoft ClarityFont AwesomejQuery MigrateSwiperRSSPriority HintsCloudwaysWPForms.

What is Amprion's email format?

Minus sign iconPlus sign icon
Amprion's email format typically follows the pattern of . Find more Amprion email formats with LeadIQ.

How much funding has Amprion raised to date?

Minus sign iconPlus sign icon
As of October 2024, Amprion has raised $5.8M in funding. The last funding round occurred on Sep 25, 2024 for $5.8M.

When was Amprion founded?

Minus sign iconPlus sign icon
Amprion was founded in 2007.
Amprion

Amprion

Biotechnology ResearchCalifornia, United States11-50 Employees

Amprion is a global leader advancing precision medicine for neurodegenerative disorders through seed amplification testing.

Amprion’s SAAmplify™-ɑSYN (formerly SYNTap®) Biomarker Test is a first-in-class, qualitative Laboratory Developed Test (LDT) and the only seed amplification assay available to aid the diagnosis of synucleinopathies such as Parkinson’s disease (PD), Lewy body dementia (LBD/DLB), and Alzheimer’s disease (AD) with Lewy body variant. 



Section iconCompany Overview

Headquarters
149 New Montgomery St 4fl San Francisco, California 94105 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
11-50

Section iconFunding & Financials

  • $5.8M

    Amprion has raised a total of $5.8M of funding over 3 rounds. Their latest funding round was raised on Sep 25, 2024 in the amount of $5.8M.

  • $10M

    Amprion's revenue is in the range of $10M

Section iconFunding & Financials

  • $5.8M

    Amprion has raised a total of $5.8M of funding over 3 rounds. Their latest funding round was raised on Sep 25, 2024 in the amount of $5.8M.

  • $10M

    Amprion's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.